The UK's energy partner.

Learn more at equinore.

Good morning from the newsroom of the Financial Times.

Today is Monday, April 15, and this is your FT news briefing.

Chinese equipment maker, Huawei, looks like it will play a role in Germany's 5G build-out, despite protests by the United

States.

Next, a technical measure of Eurozone's investors' inflation expectations has fallen to its lowest level in years.

Then the FT reports that Purdue Pharma, the makers of OxyContin, tried to profit off the rehab

therapies meant to treat opioid addicts.

I'm Mark Filipino and here's the news you need to start your day.

Despite hand-ringing from the United States, it looks like the Chinese telecoms equipment

maker, Huawei, won't be left at a Germany's 5G network build-out.

In an interview with the F.T.

Germany's federal network agency president Yakin Hohmin said that it's taking a position that, quote,

no equipment supplier, including Huawei, should or may be specifically excluded.

The U.S. has put pressure on European governments to ban Huawei infrastructure from 5G networks.

There's concern that the Chinese government could use Huawei for espionage or cyber sabotage.

But Mr. Holman pointed out that banning Huawei from the process would cause problems for operators

looking to have 5G networks since they all work with

Huawei technology already. A new ban on Huawei, Mr. Homen says, would delay the rollout of the

digital networks.

The European Central Bank will have to convince doubters that it's willing to use fresh

...